Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 17.19 | 15.34 | 15.97 | 15.06 | 18.82 | 20.43 | 20.82 | 21.47 | 24.40 | 23.03 | 20.26 | 21.86 |
| Operating costs | 16.16 | 14.10 | 15.31 | 14.19 | 17.70 | 19.83 | 20.19 | 20.75 | 22.69 | 21.35 | 19.49 | 21.02 |
| EBITDA | 1.03 | 1.24 | 0.66 | 0.87 | 1.12 | 0.60 | 0.63 | 0.72 | 1.71 | 1.68 | 0.77 | 0.84 |
| EBITDA margin % | 5.99% | 8.08% | 4.13% | 5.78% | 5.95% | 2.94% | 3.03% | 3.35% | 7.01% | 7.29% | 3.80% | 3.84% |
| Depreciation & amortisation | 0.32 | 0.40 | 0.36 | 0.36 | 0.37 | 0.37 | 0.36 | 0.41 | 0.33 | 0.35 | 0.38 | 0.39 |
| Finance costs | 0.00 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.16 | 0.04 | 0.14 | 0.16 |
| Non-operating income | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.03 |
| Pre-tax profit | 0.71 | 0.82 | 0.29 | 0.49 | 0.72 | 0.21 | 0.25 | 0.30 | 1.22 | 1.29 | 0.25 | 0.32 |
| Effective tax rate % | 25.35% | 32.93% | 58.62% | 26.53% | 25.00% | 23.81% | 44.00% | 30.00% | 26.23% | 26.36% | 8.00% | 25.00% |
| Profit after tax | 0.53 | 0.55 | 0.13 | 0.37 | 0.54 | 0.16 | 0.14 | 0.21 | 0.90 | 0.95 | 0.23 | 0.25 |
| Earnings per share (Rs) | 0.31 | 0.27 | 0.06 | 0.18 | 0.26 | 0.07 | 0.06 | 0.08 | 0.36 | 0.38 | 0.09 | 0.10 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 16.16 | 29.34 | 37.83 | 44.25 | 42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.13 | 89.17 | 89.55 |
| Operating costs | 9.81 | 16.54 | 23.77 | 27.44 | 30.57 | 31.74 | 27.54 | 42.97 | 55.97 | 71.95 | 84.15 | 84.55 |
| EBITDA | 6.35 | 12.80 | 14.06 | 16.81 | 11.67 | 2.04 | 5.63 | 2.05 | 3.76 | 3.18 | 5.02 | 5.00 |
| EBITDA margin % | 39.29% | 43.63% | 37.17% | 37.99% | 27.63% | 6.04% | 16.97% | 4.55% | 6.29% | 4.23% | 5.63% | 5.58% |
| Depreciation & amortisation | 1.15 | 1.19 | 1.28 | 1.29 | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.46 | 1.45 |
| Finance costs | 1.48 | 2.14 | 1.50 | 1.04 | 0.18 | 0.11 | 0.15 | 0.11 | 0.06 | 0.07 | 0.37 | 0.50 |
| Non-operating income | -0.17 | 0.05 | 2.07 | 0.08 | 0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | -0.13 | 0.03 |
| Pre-tax profit | 3.55 | 9.52 | 13.35 | 14.56 | 10.13 | 0.52 | 0.55 | 0.53 | 2.24 | 1.67 | 3.06 | 3.08 |
| Effective tax rate % | 0.28% | -0.21% | -0.15% | 0.62% | 0.39% | 25.00% | 40.00% | 26.42% | 32.59% | 28.14% | 25.16% | |
| Profit after tax | 3.54 | 9.54 | 13.36 | 14.48 | 10.09 | 0.39 | 0.32 | 0.40 | 1.52 | 1.20 | 2.29 | 2.33 |
| Earnings per share (Rs) | 3.39 | 7.38 | 9.90 | 9.22 | 6.42 | 0.25 | 0.20 | 0.23 | 0.75 | 0.51 | 0.93 | 0.93 |
| Paid out as dividend % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | 19% | 21% | 26% | 10% | ||
| Profit CAGR | -4% | 44% | 81% | 122% | ||
| Share price CAGR | % | -17% | -31% | -41% | ||
| Average return on equity | 8% | 2% | 2% | 2% |
| Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net block (property, plant) | 18.54 | 17.12 | 17.32 | 17.71 | 20.85 | 21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | 15.02 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 3.51 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Current & other assets | 11.62 | 12.22 | 32.25 | 49.26 | 62.00 | 71.74 | 72.31 | 72.09 | 79.62 | 91.62 | 109.54 | 129.09 |
| Total assets | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 144.12 |
| Share capital | 5.33 | 10.43 | 12.93 | 13.50 | 15.71 | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 | 24.75 |
| Reserves & surplus | 11.08 | -2.03 | 9.21 | 32.68 | 50.43 | 60.52 | 60.91 | 61.23 | 64.61 | 76.66 | 83.13 | 85.47 |
| Total debt | 10.46 | 13.94 | 10.94 | 10.90 | 1.41 | 1.30 | 1.03 | 1.25 | 1.55 | 1.41 | 1.15 | 3.96 |
| Other liabilities & provisions | 3.29 | 7.00 | 16.51 | 13.40 | 15.30 | 15.46 | 14.61 | 12.44 | 13.28 | 8.87 | 16.22 | 29.94 |
| Equity + liabilities | 30.16 | 29.34 | 49.59 | 70.48 | 82.85 | 92.99 | 92.26 | 90.63 | 96.48 | 107.32 | 123.93 | 144.12 |
| Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.00 | 3.04 | 2.28 | 12.92 | 2.62 | 2.68 | 0.22 | -0.57 | -6.59 | -12.48 | -6.60 | -3.59 |
| Investing cash flow | 0.00 | 0.00 | -1.40 | -12.90 | -11.53 | -1.94 | -0.08 | -0.05 | 0.26 | -0.30 | -0.14 | -2.25 |
| Free cash flow (after capex) | 0.00 | 3.04 | 0.88 | 7.74 | 1.70 | 0.87 | 0.06 | -0.63 | -6.34 | -12.79 | -6.74 | -5.83 |
| Financing cash flow | 0.00 | -2.91 | -0.95 | 0.21 | 13.07 | -1.77 | -0.37 | 0.07 | 5.06 | 13.64 | 8.01 | 3.97 |
| Net change in cash | 0.00 | 0.13 | -0.08 | 0.23 | 4.16 | -1.03 | -0.23 | -0.55 | -1.27 | 0.86 | 1.27 | -1.87 |
| Cash conversion (OCF / EBITDA) % | 0% | 48% | 18% | 92% | 16% | 23% | 18% | -6% | -311% | -332% | -207% | -71% |
| Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on capital employed % | 5.08% | 42.08% | 32.94% | 25.03% | 14.21% | 0.81% | 5.62% | 0.79% | 2.53% | 1.69% | 3.22% | |
| Receivable days | 50.24 | 181.82 | 229.90 | 170.49 | 159.86 | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 61.26 | 97.09 |
| Inventory days | 34.08 | 269.62 | 432.36 | 596.97 | 773.64 | 825.88 | 890.81 | 1,182.75 | 683.64 | 445.05 | 326.33 | 239.32 |
| Payable days | 31.06 | 264.36 | 447.94 | 173.22 | 185.88 | 153.84 | 112.09 | 146.00 | 123.28 | 41.39 | 68.52 | 99.44 |
| Cash cycle (days) | 53.25 | 187.08 | 214.32 | 594.24 | 747.62 | 849.70 | 913.46 | 1,177.82 | 657.58 | 464.10 | 319.07 | 236.98 |
| Working capital days | 51.72 | -155.17 | 193.82 | 240.82 | 321.94 | 421.77 | 545.99 | 603.01 | 502.26 | 477.19 | 423.69 | 384.77 |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter group % | 19.27% | 16.12% | 16.12% | 16.12% | 15.66% | 18.26% | 19.46% | 18.42% | 18.42% | 18.42% | 19.46% | 19.46% |
| Domestic institutions % | 7.80% | 6.53% | 6.53% | 6.53% | 6.34% | 5.87% | 5.68% | 5.37% | 5.37% | 5.37% | 5.68% | 5.68% |
| Retail & others % | 72.92% | 77.35% | 77.35% | 77.35% | 78.02% | 75.89% | 74.87% | 76.20% | 76.21% | 76.20% | 74.87% | 74.86% |
| Shareholder count | 1,645 | 2,041 | 2,737 | 3,002 | 3,154 | 3,416 | 3,614 | 3,667 | 3,743 | 3,926 | 4,004 | 4,084 |
Fundamentals
Market value₹ 29.4 Cr.
Last price₹ 11.9
P/E (trailing)12.6
Book value / share₹ 44.5
Return on capital3.22 %
Return on equity2.21 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)10%
Profit CAGR (TTM)122%
Standalone figures.
Valuation
Market capRs 29 Cr
Enterprise valueRs 31 Cr
P/E (TTM)12.43x
Price to book0.26x
Price to sales0.32x
EV / EBITDA6.22x
EV / EBIT8.74x
EV / sales0.35x
Earnings yield8.05%
P/E, 3-year average25.83x
P/B, 3-year average0.37x
P/E, 5-year average74.04x
P/B, 5-year average0.48x
Profitability
Operating margin (excl. other income)5.63%
Operating margin (incl. other income)5.48%
EBITDA margin5.62%
Pre-tax margin3.44%
Net profit margin2.60%
Net margin, latest quarter1.14%
ROE2.11%
ROCE3.09%
ROA1.71%
ROE, 3-year average1.66%
ROCE, 3-year average2.44%
ROA, 3-year average1.41%
ROE, 5-year average1.18%
ROCE, 5-year average1.80%
ROA, 5-year average1.00%
ROIC (approx.)2.38%
Tax rate25.16%
Other income / net worth-0.12%
Growth
Sales growth (latest year)18.69%
Profit growth (latest year)90.83%
Sales CAGR, 3 years25.59%
Sales CAGR, 5 years21.43%
Profit CAGR, 3 years78.89%
Profit CAGR, 5 years42.48%
Sales growth QoQ7.90%
Profit growth QoQ8.70%
Sales growth YoY (latest quarter)1.82%
Profit growth YoY (latest quarter)19.05%
Per share
EPS (TTM)Rs 0.94
EPS (latest year)Rs 0.93
EPS (latest quarter)Rs 0.10
EPS, 3-year averageRs 0.73
EPS, 5-year averageRs 0.52
Book value per shareRs 44.53
Sales per shareRs 36.18
Cash flow per shareRs -1.45
Efficiency
Asset turnover0.62x
Fixed asset turnover5.94x
Inventory turnover1.66x
Inventory days220 days
Debtor days97 days
Debtors turnover3.76x
Leverage
Total debtRs 4 Cr
Cash and bankRs 2 Cr
Net debtRs 2 Cr
Debt to equity0.04x
Net debt / EBITDA0.46x
Interest coverage7.16x
Owners' fund to total sources76.48%
Debt to assets2.75%
Cash flow
Operating cash flow (latest year)Rs -4 Cr
Investing cash flow (latest year)Rs -2 Cr
Financing cash flow (latest year)Rs 4 Cr
Net change in cash (latest year)Rs -2 Cr
Statement figures
Net sales (TTM)Rs 90 Cr
Net sales (latest year)Rs 89 Cr
Sales (latest quarter)Rs 22 Cr
Operating profit excl. other income (latest year)Rs 5 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs -0 Cr
EBITDA (TTM)Rs 5 Cr
PBDT (TTM)Rs 5 Cr
Profit before tax (TTM)Rs 3 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 66 Cr
Total expenditure (latest year)Rs 84 Cr
Total income (latest year)Rs 89 Cr
Share capitalRs 25 Cr
ReservesRs 85 Cr
Shareholders' fundsRs 110 Cr
Total assetsRs 144 Cr
Net blockRs 15 Cr
InvestmentsRs 0 Cr
ReceivablesRs 24 Cr
InventoryRs 40 Cr
Other liabilitiesRs 30 Cr
Shares outstanding (crore)2.47
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 12.4 is at the 20th percentile of its own 7.8-year range
(median 42.3, low 3.8, high 364.3).
P/B 0.26 is at the 1th percentile (median 0.94).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 542248 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.8% | -2.8% | +1.0 pts |
| 1 month | -11.4% | -6.8% | -4.6 pts |
| 3 months | -10.5% | -7.6% | -2.9 pts |
| 3 years | -67.4% | +14.2% | -81.5 pts |
| 5 years | -57.6% | +27.9% | -85.5 pts |
Red flags
F-score 4 of 8| explain | Weak cash conversion Cash from operations was -452% of net profit over the last 3 years |
| explain | Receivables outrunning sales Receivables grew 88% vs sales +19% in 2026 |
| explain | Share dilution Share count up 6% in a year, 45% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹22 Cr +1.8% vs Jun 2025.
Net profit ₹0 Cr +19.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Deccan Health Care Ltd?
Deccan Health Care Ltd (542248) has a market capitalisation of Rs 29.4 Cr. at the 2026-10-01 close.
What is the P/E ratio of Deccan Health Care Ltd?
Deccan Health Care Ltd trades at a P/E of 12.6 on trailing twelve-month profit, at the 2026-10-01 close.
What were Deccan Health Care Ltd's latest quarterly results?
In the Jun 2026 quarter, Deccan Health Care Ltd sales was Rs 22 Cr (+1.8% vs Jun 2025) and net profit was Rs 0 Cr.